POLYLYSINE DOMAIN OF K-RAS 4B PROTEIN IS CRUCIAL FOR MALIGNANT TRANSFORMATION

被引:70
作者
JACKSON, JH
LI, JW
BUSS, JE
DER, CJ
COCHRANE, CG
机构
[1] UNIV N CAROLINA, DEPT PHARMACOL, CHAPEL HILL, NC 27599 USA
[2] IOWA STATE UNIV SCI & TECHNOL, DEPT BIOCHEM & BIOPHYS, AMES, IA 50011 USA
关键词
ISOPRENYLATION; KI-RAS; MEMBRANE ASSOCIATION; TRANSFORMING ACTIVITY; CARBOXYL-TERMINAL PROCESSING;
D O I
10.1073/pnas.91.26.12730
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Previous studies have shown that posttranslational modifications are required for both oncogenic K-ras 4B protein membrane binding and transforming activity. In addition, Hancock et al. [Hancock, J. F., Patterson, Il. and Marshall, C. J. (1990) Cell 63, 133-139] found that a polylysine domain contained at the C terminus of K-ras 4B was also absolutely essential for Ii-ras 4B membrane binding but, surprisingly, neither the polylysine domain nor membrane binding was required for transforming activity. We have performed similar studies, but our results are distinctly different, Our studies indicate that the polylysine domain is crucial for Ii-ras 4B transforming activity. Moreover, we demonstrate that although the polylysine domain increases K-ras 4B membrane binding, significant amounts of membrane binding can occur in the absence of this domain. Finally, while our studies are consistent with the notion that membrane binding is required for K-ras 4B transforming activity, we show that membrane binding, in and of itself, is not sufficient for efficient K-ras 4B transforming activity.
引用
收藏
页码:12730 / 12734
页数:5
相关论文
共 37 条
[1]   RAS GENES [J].
BARBACID, M .
ANNUAL REVIEW OF BIOCHEMISTRY, 1987, 56 :779-827
[2]   ACTIVATION OF THE CELLULAR PROTO-ONCOGENE PRODUCT P21RAS BY ADDITION OF A MYRISTYLATION SIGNAL [J].
BUSS, JE ;
SOLSKI, PA ;
SCHAEFFER, JP ;
MACDONALD, MJ ;
DER, CJ .
SCIENCE, 1989, 243 (4898) :1600-1603
[3]   DIRECT IDENTIFICATION OF PALMITIC ACID AS THE LIPID ATTACHED TO P21RAS [J].
BUSS, JE ;
SEFTON, BM .
MOLECULAR AND CELLULAR BIOLOGY, 1986, 6 (01) :116-122
[4]   ACTIVATION OF KI-RAS 2 GENE IN HUMAN-COLON AND LUNG CARCINOMAS BY 2 DIFFERENT POINT MUTATIONS [J].
CAPON, DJ ;
SEEBURG, PH ;
MCGRATH, JP ;
HAYFLICK, JS ;
EDMAN, U ;
LEVINSON, AD ;
GOEDDEL, DV .
NATURE, 1983, 304 (5926) :507-513
[5]   P21RAS IS MODIFIED BY A FARNESYL ISOPRENOID [J].
CASEY, PJ ;
SOLSKI, PA ;
DER, CJ ;
BUSS, JE .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (21) :8323-8327
[6]   CONSTRUCTION AND APPLICATIONS OF A HIGHLY TRANSMISSIBLE MURINE RETROVIRUS SHUTTLE VECTOR [J].
CEPKO, CL ;
ROBERTS, BE ;
MULLIGAN, RC .
CELL, 1984, 37 (03) :1053-1062
[7]   A DIFFUSION ASSAY FOR DETECTION AND QUANTITATION OF METHYL-ESTERIFIED PROTEINS ON POLYACRYLAMIDE GELS [J].
CHELSKY, D ;
GUTTERSON, NI ;
KOSHLAND, DE .
ANALYTICAL BIOCHEMISTRY, 1984, 141 (01) :143-148
[8]   POSTTRANSLATIONAL MODIFICATION OF THE HA-RAS ONCOGENE PROTEIN - EVIDENCE FOR A 3RD CLASS OF PROTEIN CARBOXYL METHYLTRANSFERASES [J].
CLARKE, S ;
VOGEL, JP ;
DESCHENES, RJ ;
STOCK, J .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (13) :4643-4647
[9]   SPECIFIC ISOPRENOID MODIFICATION IS REQUIRED FOR FUNCTION OF NORMAL, BUT NOT ONCOGENIC, RAS PROTEIN [J].
COX, AD ;
HISAKA, MM ;
BUSS, JE ;
DER, CJ .
MOLECULAR AND CELLULAR BIOLOGY, 1992, 12 (06) :2606-2615
[10]  
Der C. J., 1989, ONCOGENES, P74